Nirav Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nirav Patel has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Abhishek Shenoy
Division of Medicine, University of Virginia, Charlottesville, VA, United States
3 shared publicationsCaroline Donahue
NYU School of Medicine, NY, United States
3 shared publicationsNabil El-Sherif
Division of Cardiology, Brooklyn VA Center, Brooklyn, NY, United States
3 shared publicationsOlivia Chen
NYU School of Medicine, NY, United States
2 shared publications- Yixin Fang
Department of Mathematical Sciences, New Jersey Institute of Technology, Newark, New Jersey, USA
2 shared publications - Abhishek Jaiswal
Hartford Healthcare Heart and Vascular Institute, Hartford Hospital, Hartford, CT
1 shared publication
Latest Publications
- Open Access
- 27 June 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (7) , 249
Role of Computed Tomography and Other Non-Invasive and Invasive Imaging Modalities in Cardiac Allograft Vasculopathy
Cardiac allograft vasculopathy (CAV) is a leading cause of allograft dysfunction and failure. CAV prevention, early detection, and management are essential to increasing allograft survival. In this comprehensive review, we discuss various invasive and non-invasive modalities that are being utilized for CAV detection. Invasive coronary angiography provides a visualization of vascular anatomy but is limited in detecting the microvasculature and diffuse and early structural changes. The addition of intracoronary assessment techniques, including intravascular ultrasound, optical coherence tomography, and coronary flow reserve assessment, offer(s) superior sensitivity in identifying CAV. Non-invasive imaging modalities, such as cardiac magnetic resonance imaging, computed tomography angiography, and positron emission tomography, provide complementary insights into CAV with myocardial perfusion and allograft function while reducing procedural risks. Our aim is to guide clinicians in selecting appropriate imaging strategies tailored to individual recipients, to improve detection, monitoring, and outcomes in CAV.
- 27 June 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (7) , 249
Open AccessRole of Computed Tomography and Other Non-Invasive and Invasive Imaging Modalities in Cardiac Allograft Vasculopathy
Cardiac allograft vasculopathy (CAV) is a leading cause of allograft dysfunction and failure. CAV prevention, early detection, and management are essential to increasing allograft survival. In this comprehensive review, we discuss various invasive and non-invasive modalities that are being utilized for CAV detection. Invasive coronary angiography provides a visualization of vascular anatomy but is limited in detecting the microvasculature and diffuse and early structural changes. The addition of intracoronary assessment techniques, including intravascular ultrasound, optical coherence tomography, and coronary flow reserve assessment, offer(s) superior sensitivity in identifying CAV. Non-invasive imaging modalities, such as cardiac magnetic resonance imaging, computed tomography angiography, and positron emission tomography, provide complementary insights into CAV with myocardial perfusion and allograft function while reducing procedural risks. Our aim is to guide clinicians in selecting appropriate imaging strategies tailored to individual recipients, to improve detection, monitoring, and outcomes in CAV.
- 16 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (10) , e028396
Survey Study of the Real‐World Outpatient Management of Postoperative Atrial Fibrillation
- 16 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (10) , e028396
Survey Study of the Real‐World Outpatient Management of Postoperative Atrial Fibrillation
- 1 April 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (4) , 287-297
Impact of Obesity on Ventricular Assist Device Outcomes
- 1 April 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (4) , 287-297
Impact of Obesity on Ventricular Assist Device Outcomes
- Open Access
- 6 May 2019
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 15 (3) , 230-238
Cryoballoon Ablation for the Treatment of Atrial Fibrillation: A Meta-analysis
Background: Ablation therapy is the treatment of choice in antiarrhythmic drugrefractory atrial fibrillation (AF). It is performed by either cryoballoon ablation (CBA) or radiofrequency ablation. CBA is gaining popularity due to simplicity with similar efficacy and complication rate compared with RFA. In this meta-analysis, we compare the recurrence rate of AF and the complications from CBA versus RFA for the treatment of AF. Methods: We systematically searched PubMed for the articles that compared the outcome of interest. The primary outcome was to compare the recurrence rate of AF between CBA and RFA. We also included subgroup analysis with complications of pericardial effusion, phrenic nerve palsy and cerebral microemboli following ablation therapy. Results: A total of 24 studies with 3527 patients met our predefined inclusion criteria. Recurrence of AF after CBA or RFA was similar in both groups (RR: 0.84; 95% CI: 0.65, 1.07; I2=48%, Cochrane p=0.16). In subgroup analysis, heterogeneity was less in paroxysmal AF (I2=0%, Cochrane p=0.46) compared to mixed AF (I2=72%, Cochrane p=0.003). Procedure and fluoroscopy time was less by 26.37 and 5.94 minutes respectively in CBA compared to RFA. Complications, pericardial effusion, and silent cerebral microemboli, were not different between the two groups, however, phrenic nerve palsy was exclusively present only in CBA group. Conclusion: This study confirms that the effectiveness of CBA is similar to RFA in the treatment of AF with the added advantages of shorter procedure and fluoroscopy times.
- 6 May 2019
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 15 (3) , 230-238
Open AccessCryoballoon Ablation for the Treatment of Atrial Fibrillation: A Meta-analysis
Background: Ablation therapy is the treatment of choice in antiarrhythmic drugrefractory atrial fibrillation (AF). It is performed by either cryoballoon ablation (CBA) or radiofrequency ablation. CBA is gaining popularity due to simplicity with similar efficacy and complication rate compared with RFA. In this meta-analysis, we compare the recurrence rate of AF and the complications from CBA versus RFA for the treatment of AF. Methods: We systematically searched PubMed for the articles that compared the outcome of interest. The primary outcome was to compare the recurrence rate of AF between CBA and RFA. We also included subgroup analysis with complications of pericardial effusion, phrenic nerve palsy and cerebral microemboli following ablation therapy. Results: A total of 24 studies with 3527 patients met our predefined inclusion criteria. Recurrence of AF after CBA or RFA was similar in both groups (RR: 0.84; 95% CI: 0.65, 1.07; I2=48%, Cochrane p=0.16). In subgroup analysis, heterogeneity was less in paroxysmal AF (I2=0%, Cochrane p=0.46) compared to mixed AF (I2=72%, Cochrane p=0.003). Procedure and fluoroscopy time was less by 26.37 and 5.94 minutes respectively in CBA compared to RFA. Complications, pericardial effusion, and silent cerebral microemboli, were not different between the two groups, however, phrenic nerve palsy was exclusively present only in CBA group. Conclusion: This study confirms that the effectiveness of CBA is similar to RFA in the treatment of AF with the added advantages of shorter procedure and fluoroscopy times.
- 4 January 2019
- Published by Wiley in Artificial Organs
- Vol. 43 (7) , 699-700
Mobile inflow cannula leading to positional ventricular tachycardia
- 4 January 2019
- Published by Wiley in Artificial Organs
- Vol. 43 (7) , 699-700
Mobile inflow cannula leading to positional ventricular tachycardia
- Open Access
- 6 May 2018
- Published by Springer Nature in Cureus
- Vol. 10 (5) , e2584
Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review
Postoperative atrial fibrillation (POAF) remains a major risk after cardiac surgery and is associated with an increased risk of stroke, length of stay, mortality, and cost. Ranolazine, an anti-anginal drug, also has anti-arrhythmic properties. The present study is to evaluate the effectiveness of ranolazine in preventing POAF after cardiac surgery. We searched the literature for clinical studies published up to August 2017 with a pre-defined inclusion and exclusion criteria. We identified four studies with a total of 754 patients of which 300 patients received ranolazine; there was a 14% decrease in POAF occurrence following cardiac surgery compared to 32% in the control group. Although ranolazine is an effective therapy in prevention of POAF, larger, multi-center, randomized trials are warranted.
- 6 May 2018
- Published by Springer Nature in Cureus
- Vol. 10 (5) , e2584
Open AccessRanolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review
Postoperative atrial fibrillation (POAF) remains a major risk after cardiac surgery and is associated with an increased risk of stroke, length of stay, mortality, and cost. Ranolazine, an anti-anginal drug, also has anti-arrhythmic properties. The present study is to evaluate the effectiveness of ranolazine in preventing POAF after cardiac surgery. We searched the literature for clinical studies published up to August 2017 with a pre-defined inclusion and exclusion criteria. We identified four studies with a total of 754 patients of which 300 patients received ranolazine; there was a 14% decrease in POAF occurrence following cardiac surgery compared to 32% in the control group. Although ranolazine is an effective therapy in prevention of POAF, larger, multi-center, randomized trials are warranted.
- 1 November 2017
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 31 (11) , 1597-1601
Impact of diabetes on heart failure incidence in adults with ischemic heart disease
- 1 November 2017
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 31 (11) , 1597-1601
Impact of diabetes on heart failure incidence in adults with ischemic heart disease
- Open Access
- 26 September 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 9 (9) , 731-736
Obesity paradox in patients undergoing coronary intervention: A review
Obesity paradox in patients undergoing coronary intervention: A review
- 26 September 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 9 (9) , 731-736
Open AccessObesity paradox in patients undergoing coronary intervention: A review
Obesity paradox in patients undergoing coronary intervention: A review
- 1 August 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (8) , S74-S75
Impact of Diabetes on Heart Failure Incidence in Adults with Ischemic Heart Disease
- 1 August 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (8) , S74-S75
Impact of Diabetes on Heart Failure Incidence in Adults with Ischemic Heart Disease